Integration Delivers Seamless Workflow Combining AI-Powered Cancer Diagnosis with CAP, RCPath, and ICCR-Compliant ...

March 11, 2026 – New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has demonstrated that OGM provided reliable and robust analytical ...

AI-powered digital workflow brings greater consistency, efficiency, and collaboration to bone marrow morphologyCellaVision today announced the launch of the CellaVision® Bone Marrow Aspirate (BMA) ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help ...

Adding Voicebrook strengthens our ecosystem by introducing speech-enabled workflow capabilities designed to streamline ...

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has announced the publication 1 in the Journal of Clinical Pathology of a study conducted in collaboration with the Memorial ...

In many skilled nursing facilities, speech-language pathologists are brought in to address individual issues. But an alternative framing is more powerful.

Fujifilm’s AI-driven medical informatics solutions that will be highlighted at booth #1617 include: ...

The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

Artificial intelligence has a critical role to play in supporting clinicians beyond the initial breast cancer diagnosis. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting in ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...